Table 1.
.
| microRNA ID | Target | Relevance/disease | Reference |
| RedoximiRs | |||
| miR-144 | Nrf2 | Sickle cell disease | [94] |
| miR-28 | Nrf2 | Breast cancer | [95] |
| miR-27b | Nrf2 | Liver fibrosis | [96] |
| miR-34a | Nrf2 | Liver aging | [97–99] |
| miR-132 | Nrf2 | Nephrotoxicity | [89] |
| miR-200a | Keap1 | Breast cancer/fibrosis | [92,100] |
| miR-155 | Bach1 | Cardiovascular diseases, carcinomas | [101–103] |
| MitomiRs | |||
| miR-27 | MFF | Mitochondrial fission | [113] |
| miR-34a | Txnrd2 | Renal senescence | [114] |
| miR-145 | Bnip3 | [115] | |
| miR181a | Bcl-2 | Heart disease | [116] |
| miR-210 | ISCU/ AIFM3 | Hypoxia/cancer | [117] |
| miR-335 | SOD2 | Renal senescence | [114] |
| miR-494 | Foxj3/ mtF2 | Skeletal muscle differentiation | [118] |
| HipoxymiRs | |||
| miR-155 | HK2 | Hypertension | [122] |
| miR-210 | GPD1L/ISCU/COX10 | [123] | |
| miR-200 | PHD2 | Ischemia/precondition | [124] |
| miR-1/133 | Hsp60/ Hsp70/ IGF-1/ Bcl-2 | Ischemia/precondition | [124] |
| miR-34a | Sirt1 | Cardiovascular disease/myocardial infartation | [125] |